Evidence map›Paper›PMID 31713515›Full record

ArticleeLife2019

Cycles of autoubiquitination and deubiquitination regulate the ERAD ubiquitin ligase Hrd1.

Brian G Peterson, Morgan L Glaser, Tom A Rapoport, Ryan D Baldridge

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Competition between Der1 and ERAD-M substrates controls Hrd1 complex function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. SEL1L-HRD1-mediated ERAD in mammals.Nature cell biology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Brian G PetersonDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, United States.ORCID 0000-0001-6871-2336
Morgan L GlaserDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, United States.
Tom A RapoportDepartment of Cell Biology, Harvard Medical School, Howard Hughes Medical Institute, Boston, United States.ORCID 0000-0001-9911-4216
Ryan D BaldridgeDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, United States.ORCID 0000-0001-7158-7812
University of Michigan · USHoward Hughes Medical Institute · US

Funding

PROTEIN TRANSPORT INTO MAMMALIAN ENDOPLASMIC RETICULUMR01GM052586 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Tom A Rapoport · 1995 to 2026
$11.9M
PREDOCTORAL TRAINING IN GENETICST32GM007544 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORAN, JOHN V. · 1985 to 2022
$11.3M
Protein quality control at eukaryotic membranes.R35GM128592 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ryan Douglas Baldridge · 2018 to 2026
$3.3M
Damon Runyon Cancer Research Foundation DFS-26-18Damon Runyon Cancer Research Foundation DRG-2184-14NIGMS NIH HHS Michigan Predoctoral Training in Genetics (T32GM007544)NIGMS NIH HHS R01 GM052586NIGMS NIH HHS R01GM052586NIGMS NIH HHS R35 GM128592NIGMS NIH HHS R35GM128592NIGMS NIH HHS T32 GM007544University of Michigan Medical School Biological Sciences Scholars Program
6 · The paper itself

Abstract

Misfolded proteins in the lumen of the endoplasmic reticulum (ER) are retrotranslocated into the cytosol and polyubiquitinated before being degraded by the proteasome. The multi-spanning ubiquitin ligase Hrd1 forms the retrotranslocation channel and associates with three other membrane proteins (Hrd3, Usa1, Der1) of poorly defined function. The Hrd1 channel is gated by autoubiquitination, but how Hrd1 escapes degradation by the proteasome and returns to its inactive ground state is unknown. Here, we show that autoubiquitination of Hrd1 is counteracted by Ubp1, a deubiquitinating enzyme that requires its N-terminal transmembrane segment for activity towards Hrd1. The Hrd1 partner Hrd3 serves as a brake for autoubiquitination, while Usa1 attenuates Ubp1's deubiquitination activity through an inhibitory effect of its UBL domain. These results lead to a model in which the Hrd1 channel is regulated by cycles of autoubiquitination and deubiquitination, reactions that are modulated by the other components of the Hrd1 complex.

Indexed as

Endoplasmic Reticulum-Associated DegradationUbiquitinationEndoplasmic ReticulumEnzyme StabilityIntracellular MembranesMembrane GlycoproteinsProtein DomainsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsUbiquitin-Protein LigasesHRD1 protein, S cerevisiaeHRD3 protein, S cerevisiaeMembrane GlycoproteinsSaccharomyces cerevisiae ProteinsUbiquitin-Protein Ligasesbiochemistrycell biologychemical biologyERADprotein degradationprotein quality controlregulationS. cerevisiae

Identifiers

PMID31713515
PMCPMC6914336
OpenAlexW2985045121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.